Questions: Electrolyte Balance and Renal-Hormonal Control

Question 1

A patient with Conn syndrome (primary hyperaldosteronism — autonomous excess aldosterone secretion) presents with hypertension and profound muscle weakness. Which electrolyte abnormality most directly explains the weakness?

• A. Hypernatremia — excess sodium raises osmolality and impairs neuromuscular transmission
• B. Hypokalemia — excess aldosterone drives potassium secretion into the tubular fluid; low plasma K⁺ hyperpolarizes cell membranes, impairing muscle excitability
• C. Hyperkalemia — the sodium retention from aldosterone excess crowds out potassium in the blood
• D. Hypocalcemia — aldosterone indirectly suppresses PTH, reducing calcium absorption

Answer: (B)

Aldosterone acts on collecting duct principal cells to increase both ENaC (apical sodium channels) and Na⁺/K⁺-ATPase (basolateral pumps). More sodium is reabsorbed from tubular fluid, and to maintain electrochemical balance, more potassium is secreted into the tubular fluid for excretion. In aldosterone excess, this process operates continuously, driving potassium out of the body. The resulting hypokalemia lowers plasma K⁺, which hyperpolarizes cell membranes (the Nernst equation: lower extracellular K⁺ makes the resting potential more negative), reducing membrane excitability and causing weakness. Option C is backwards: sodium retention and potassium loss move in opposite directions under aldosterone.

Question 2

Why does RAAS activation simultaneously increase sodium reabsorption AND increase potassium excretion, rather than affecting only sodium?

• A. Angiotensin II directly stimulates two independent channels — one for sodium reabsorption, one for potassium excretion
• B. Aldosterone's mechanism in principal cells — upregulating both ENaC (apical Na⁺ entry) and Na⁺/K⁺-ATPase (basolateral pumping) — creates a sodium-for-potassium exchange that mechanistically couples the two effects
• C. The kidneys must maintain electrical neutrality by secreting a cation (K⁺) whenever another cation (Na⁺) is reabsorbed
• D. Aldosterone separately acts on the thick ascending limb to excrete potassium while acting on the collecting duct to retain sodium

Answer: (B)

Aldosterone upregulates ENaC channels on the apical membrane of principal cells (allowing Na⁺ to flow from tubular fluid into the cell) and Na⁺/K⁺-ATPase pumps on the basolateral membrane (pumping Na⁺ into the blood while bringing K⁺ into the cell from the blood). The net result: sodium moves from tubular fluid → cell → blood; potassium moves from blood → cell → tubular fluid → urine. The sodium-potassium exchange is mechanistically built into the machinery — not two separate processes, but two faces of the same pump-channel system. Option C contains a germ of truth (electrochemical balance matters) but is oversimplified; the Na⁺/K⁺-ATPase stoichiometry (3 Na⁺ out, 2 K⁺ in) is the mechanistic heart.

Question 3

Aldosterone's primary physiological role is sodium retention; its effect on potassium is a minor side effect that rarely has clinical significance.

• T. True
• F. False

Answer: False

False. The coupling between sodium reabsorption and potassium secretion under aldosterone is mechanistically central, not a side effect. Clinically, potassium dysregulation is the most dangerous consequence of aldosterone abnormalities: aldosterone excess causes hypokalemia (muscle weakness, cardiac arrhythmias), while aldosterone deficiency causes hyperkalemia (which can trigger fatal ventricular arrhythmias more acutely dangerous than the hyponatremia/hypotension of Addison's disease). Potassium-sparing diuretics exist precisely to exploit this connection. Framing potassium effects as 'minor' misses that hyperkalemia is one of the most medically urgent electrolyte emergencies.

Question 4

Atrial natriuretic peptide (ANP) and the renin-angiotensin-aldosterone system (RAAS) work in opposing directions to regulate sodium balance and blood volume.

• T. True
• F. False

Answer: True

True. RAAS is activated by volume depletion and acts to conserve sodium, retain water, and expand blood volume. ANP is released by atrial cardiomyocytes when they are physically stretched by volume excess, and it acts in the opposite direction: inhibiting renin secretion, blocking aldosterone release, and directly increasing renal sodium excretion (natriuresis), while also causing vasodilation. The two systems form a push-pull regulatory axis: RAAS restores volume when depleted, ANP sheds volume when overloaded. Drugs targeting RAAS (ACE inhibitors, ARBs, aldosterone antagonists) are foundational treatments for hypertension and heart failure because disrupting the RAAS-ANP balance underlies both conditions.

Question 5

Why might a patient with severe aldosterone deficiency (Addison's disease) develop a life-threatening cardiac arrhythmia, and which electrolyte imbalance is responsible?

Model answer: Without aldosterone, collecting duct principal cells have reduced ENaC and Na⁺/K⁺-ATPase activity. Potassium secretion into the tubular fluid is severely diminished, so potassium accumulates in the blood — hyperkalemia. Elevated extracellular K⁺ raises (depolarizes) the resting membrane potential of cardiac myocytes by shifting the K⁺ equilibrium potential toward zero. A depolarized resting potential inactivates voltage-gated sodium channels (they cannot recover from inactivation when the membrane is not sufficiently polarized), reducing cardiac excitability and conduction velocity. Severe hyperkalemia (K⁺ > ~6–7 mEq/L) causes conduction abnormalities, broadened QRS complexes, and ultimately ventricular fibrillation — a rapidly fatal arrhythmia.

This question requires connecting hormone mechanism → electrolyte change → membrane physiology → cardiac risk. The path is: no aldosterone → no K⁺ secretion → hyperkalemia → depolarized resting potential → sodium channel inactivation → conduction failure → arrhythmia. Students who only know 'aldosterone retains sodium' without understanding the K⁺ trade will miss the downstream cardiac consequence entirely.